Phytomedicines Used for Diabetes Mellitus in Ghana: A Systematic Search and Review of Preclinical and Clinical Evidence

被引:25
|
作者
Adinortey, Michael Buenor [1 ]
Agbeko, Rosemary [2 ]
Boison, Daniel [1 ]
Ekloh, William [1 ,3 ]
Kuatsienu, Lydia Enyonam [4 ]
Biney, Emmanuel Ekow [1 ]
Affum, Obed O. [1 ]
Kwarteng, Jeffery [1 ]
Nyarko, Alexander Kwadwo [5 ]
机构
[1] Univ Cape Coast, Sch Biol Sci, Dept Biochem, Cape Coast, Ghana
[2] Univ Cape Coast, Sch Biol Sci, Dept Mol Biol & Biotechnol, Cape Coast, Ghana
[3] Univ Ghana, Dept Biochem Cell & Mol Biol, West Africa Ctr Cell Biol Infect Dis & Pathogens, Legon, Ghana
[4] Princefield Univ Coll, Sch Pharm, Dept Pharmacol, Ho, Ghana
[5] Univ Ghana, Sch Pharm, Dept Pharmacol & Toxicol, Legon, Ghana
关键词
COSTUS-AFER; LEAVES EXTRACT; STREPTOZOTOCIN; GLUCOSE; LEAF; STEM;
D O I
10.1155/2019/6021209
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background. Available data indicate that diabetes mellitus leads to elevated cost of healthcare. This imposes a huge economic burden on households, societies, and nations. As a result many Ghanaians, especially rural folks, resort to the use of phytomedicine, which is relatively less expensive. This paper aims at obtaining information on plants used in Ghana to treat diabetes mellitus, gather and present evidence-based data available to support their uses and their mechanisms of action, and identify areas for future research. Method. A catalogue of published textbooks, monographs, theses, and peer-reviewed articles of plants used in Ghanaian traditional medicine between 1987 and July 2018 for managing diabetes mellitus was obtained and used. Results. The review identified 76 plant species belonging to 45 families that are used to manage diabetes mellitus. Leaves were the part of the plants frequently used for most preparation (63.8%) and were mostly used as decoctions. Majority of the plants belonged to the Euphorbiaceae, Lamiaceae, Asteraceae, and Apocynaceae families. Pharmacological data were available on 23 species that have undergone in vitro studies. Forty species have been studied using in vivo animal models. Only twelve plants and their bioactive compounds were found with data on both preclinical and clinical studies. The records further indicate that medicinal plants showing antidiabetic effects did so via biochemical mechanisms such as restitution of pancreatic -cell function, improvement in insulin sensitivity by receptors, stimulating rate of insulin secretion, inhibition of liver gluconeogenesis, enhanced glucose absorption, and inhibition of G-6-Pase, -amylase, and -glucosidase activities. Conclusion. This review contains information on medicinal plants used to manage diabetes mellitus, including their pharmacological properties and mechanisms of action as well as models used to investigate them. It also provides gaps that can form the basis for further investigations and development into useful medications for effective treatment of diabetes mellitus.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] GABA-modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence
    Savage, Karen
    Firth, Joseph
    Stough, Con
    Sarris, Jerome
    PHYTOTHERAPY RESEARCH, 2018, 32 (01) : 3 - 18
  • [2] Potential Effect of Hydroxychloroquine in Diabetes Mellitus: A Systematic Review on Preclinical and Clinical Trial Studies
    Wondafrash, Dawit Zewdu
    Desalegn, Tsion Zewdu
    Yimer, Ebrahim M.
    Tsige, Arega Gashaw
    Adamu, Betelhem Anteneh
    Zewdie, Kaleab Alemayehu
    JOURNAL OF DIABETES RESEARCH, 2020, 2020
  • [3] A Systematic Review of Methodologies Used in Models of the Treatment of Diabetes Mellitus
    Antoniou, Marina
    Mateus, Ceu
    Hollingsworth, Bruce
    Titman, Andrew
    PHARMACOECONOMICS, 2024, 42 (01) : 19 - 40
  • [4] A Systematic Review of Methodologies Used in Models of the Treatment of Diabetes Mellitus
    Marina Antoniou
    Céu Mateus
    Bruce Hollingsworth
    Andrew Titman
    PharmacoEconomics, 2024, 42 : 19 - 40
  • [5] Omadacycline and Clostridioides difficile: A Systematic Review of Preclinical and Clinical Evidence
    Garey, Kevin W.
    Rose, Warren
    Gunter, Kyle
    Serio, Alisa W.
    Wilcox, Mark H.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (02) : 184 - 192
  • [6] Clinical trials with plants in diabetes mellitus therapy: a systematic review
    Marmitt, Diorge Jonatas
    Shahrajabian, Mohamad Hesam
    Goettert, Marcia Ines
    Rempel, Claudete
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (06) : 735 - 747
  • [7] Cannabidiol (CBD): A Systematic Review of Clinical and Preclinical Evidence in the Treatment of Pain
    Casedas, Guillermo
    Yarza-Sancho, Martin de
    Lopez, Victor
    PHARMACEUTICALS, 2024, 17 (11)
  • [8] Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence
    Bortoletto, Riccardo
    Piscitelli, Fabiana
    Candolo, Anna
    Bhattacharyya, Sagnik
    Balestrieri, Matteo
    Colizzi, Marco
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [9] Melatonin and aggressive behavior: A systematic review of the literature on preclinical and clinical evidence
    Paribello, Pasquale
    Manchia, Mirko
    Bosia, Marta
    Pinna, Federica
    Carpiniello, Bernardo
    Comai, Stefano
    JOURNAL OF PINEAL RESEARCH, 2022, 72 (04)
  • [10] Prevalence and clinical implications of diabetes mellitus in autoimmune nodopathies: A systematic review
    Tentolouris, Anastasios
    Stefanou, Maria-Ioanna
    Vrettou, Anastasia V.
    Palaiodimou, Lina
    Moschovos, Christos
    Papadopoulou, Marianna
    Kokotis, Panagiotis
    Eleftheriadou, Ioanna
    Tentolouris, Nikolaos
    Tsivgoulis, Georgios
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2024, 38 (12)